Add BrightSurf on Google Email

Links discovered between mitochondrial lipid deficiency and inflammation of the gut

A study published in Nature Metabolism has found a crucial link between mitochondrial lipid deficiency and gut inflammation, revealing that cardiolipin plays a key role in maintaining immune homeostasis. The research suggests that targeting the metabolism of immune cells could be a new approach to treating inflammatory bowel diseases.

SourceUniversity of Cologne·JournalNature Metabolism·TypeExperimental study·DateMay 18, 2026

When cells reveal their inner workings

Researchers at Max Planck Institute for the Science of Light create a 'map' of glycocalyx by mapping individual sugar structures using super-high-resolution microscopy technology. The results show that the spatial arrangement of sugar structures relates to cell physiological state, providing a structured display to the outside world.

SourceMax Planck Institute for the Science of Light·JournalNature Nanotechnology·TypeExperimental study·DateMay 15, 2026

Data hidden in tuberculosis screening tests sheds light on patients’ overall mortality

A study by UCLA Health researchers linked low immune responses to higher mortality rates in patients, using tuberculosis screening tests as a tool. The results suggest that these tests can predict mortality in various patient groups, including those undergoing organ transplants and cancer patients on immunotherapy.

SourceUniversity of California - Los Angeles Health Sciences·JournalGeroScience·TypeData/statistical analysis·DateMay 11, 2026

New USF study tests whether AI can reliably predict immune responses

Researchers at USF Health developed a framework to test AI tools' accuracy in predicting immune responses, aiming to enhance cancer immunotherapies and vaccine development. The study highlights the strengths and weaknesses of current AI approaches, providing guidance for building safe and reliable AI tools for healthcare.

SourceUniversity of South Florida·JournalNature Machine Intelligence·TypeData/statistical analysis·DateMay 6, 2026

Disease-causing pathogen rewires gut metabolism to secure nutrients for growth: Study

Researchers at Vanderbilt University Medical Center discovered that enterotoxigenic Bacteroides fragilis reshapes intestinal cell metabolism to support its growth, causing diseases like diarrhea and colorectal cancer. The study provides new possibilities for intervention by targeting metabolic interactions between host and microbes.

SourceVanderbilt University Medical Center·JournalCell·TypeExperimental study·DateApr 30, 2026

More immune protection, less dominance: a new phase in the corona-development?

A new phase in the corona-development has been identified, with recent SARS-CoV-2 variants spreading less rapidly worldwide and BA.3.2 infecting young children more frequently than other strains. This suggests that global immunity from vaccination and infections may be making it harder for new variants to spread.

SourceDeutsches Primatenzentrum (DPZ)/German Primate Center·JournalThe Lancet Infectious Diseases·TypeCommentary/editorial·DateApr 21, 2026

Researchers identify blood-based biomarker for cancer risk in people with Lynch Syndrome

A new blood-based biomarker has been discovered to help identify individuals at higher risk of developing cancer in people with Lynch Syndrome. The biomarker uses immune signatures detected in blood samples to provide unique characteristics that can detect cancer risk, allowing for early detection and personalized surveillance.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalNature Communications·DateApr 6, 2026

Building protection against infectious diseases with nanostructured vaccines

Researchers at the Wyss Institute developed DoriVac, a DNA nanotechnology-enabled vaccine platform that induces broad immunity against infectious viruses, including SARS-CoV-2, HIV, and Ebola. The platform produces potent antigen-specific immune responses and is more stable and easier to manufacture than traditional vaccine platforms.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Biomedical Engineering·TypeExperimental study·DateMar 11, 2026

Chemotherapy candidate can marshall attention from the body’s natural defenses

Researchers discover a potential chemotherapy agent that causes cancer cells to release signals similar to those released by infected cells, triggering an immune response. This finding could lead to a new approach in cancer treatment, using lower doses of chemotherapy drugs to recruit the immune system as an ally.

SourceUniversity of Texas at Austin·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMar 11, 2026

Overcoming ovarian cancer’s resistance to immunotherapy

A new study demonstrates that blocking a signaling protein called FAK helps mobilize an anti-tumor immune response, allowing tumor-fighting cells to approach tumors and shift the behavior of other immune cells to work against them. This approach achieved the best effects on immune cell recruitment, tumor size reduction, and survival ti...

SourceSanford Burnham Prebys·JournalCell Reports·TypeExperimental study·DateMar 5, 2026

Novel cellular phenomenon reveals how immune cells extract nuclear DNA from dying cells

Immune cells have been found to selectively extract nuclear DNA from dying cells, a regulated cellular function that challenges traditional views of the nucleus. This discovery, known as nucleocytosis, may hold implications for understanding autoimmune diseases, infections, and cancer, as well as informing drug development strategies.

SourceThe Institute of Medical Science, The University of Tokyo·JournalNature Communications·TypeExperimental study·DateFeb 25, 2026

How age, sex and genetics shape our antibodies

A study found that age, biological sex, and human genetic factors determine the quantity and specificity of antibodies produced in response to viral infections. The research has significant implications for vaccine and therapeutic design, as it shows that individual profiles can be tailored to improve treatment effectiveness.

SourceInstitut Pasteur·JournalNature Immunology·TypeCase study·DateFeb 18, 2026

Study reveals how chills develop and support the body's defense against infection

A recent rat study identified the neural mechanism underlying chills, a cold sensation that supports the body's response to infection. The findings suggest that prostaglandin E₂ boosts cold signals from the lateral parabrachial nucleus to the central nucleus of the amygdala, triggering chills and promoting warmth-seeking behavior.

SourceNagoya University·JournalThe Journal of Physiology·TypeExperimental study·DateFeb 10, 2026

Could these two genes make T cells unstoppable?

Researchers at Salk Institute uncover two transcription factors, ZSCAN20 and JDP2, that determine T cell fate. Turning off these genes reverses T cell exhaustion and restores their ability to kill tumors without losing immune memory. The study challenges the long-standing belief of inevitable immune exhaustion.

SourceSalk Institute·JournalNature·DateFeb 4, 2026

Gut microbe–derived butyrate activates immune cells to enhance vaccine efficacy

A study published in Microbiome found that gut microbiome-derived butyrate activates immune cells to enhance vaccine efficacy by promoting T follicular helper (Tfh) cell activity and mucosal antibody production. This discovery highlights the crucial role of gut environment regulation in controlling infections and enhancing vaccine resp...

Preparedness for future pandemics: MERS vaccine candidate shows long-lasting immune response

A new MERS vaccine candidate has shown a stable and functional immune response in humans that persists for at least two years after a booster vaccination. The study demonstrates that such durable immunity can be achieved through targeted booster vaccinations, providing an important step toward an effective MERS vaccine.

SourceGerman Center for Infection Research·JournalNature Communications·TypeRandomized controlled/clinical trial·DateJan 28, 2026

How do nature and nurture shape our immune cells?

Researchers at Salk Institute debut an epigenetic catalog that shows genetic inheritance and life experiences have distinct effects on various types of immune cells, shedding light on individual differences in immune responses and potential new personalized therapeutics.

SourceSalk Institute·JournalNature Genetics·DateJan 27, 2026

Sequestered in immune cells, barium titanate nanoparticles stimulated by ultrasound launch inflammatory response

Boston College researchers used piezoelectric nanoparticles to trigger macrophages, a key part of the body's immune response. The study suggests that this method could be used to activate immune cells specifically at an infection or tumor site, avoiding side effects associated with systemic administration of drugs.

SourceBoston College·JournalScientific Reports·TypeExperimental study·DateJan 14, 2026